Medicover (MCOV B.ST) Stock Price
Medicover Price
Over the last 20 years Medicover grew revenue by 20.3% annually, reaching 2.38 B EUR. Earnings per share have grown at 22.3% per year over the last 20 years. For Medicover, the net margin of 3.3% is down versus 7.4% a few years ago. At today's price the dividend yield works out to roughly 0.65%. The payout ratio is around 29% of earnings. The dividend has grown at 21.0% per year over the past 4 years. The consensus 12-month price target for Medicover is 22.81 EUR, about 1.2% below where the stock trades today. Of 9 analysts, 5 rate the stock a buy — an overall Buy consensus.
Medicover stock price
Medicover business model & stock analysis
Frequently asked questions about Medicover
The business model of Medicover AB revolves around providing a comprehensive range of healthcare services to individuals, families, and corporate clients. Medicover AB operates a network of medical clinics, hospitals, and laboratories, offering a wide range of healthcare services such as primary care, specialized care, diagnostics, and outpatient surgery. By integrating healthcare facilities and services, Medicover AB aims to provide high-quality medical care, convenience, and efficient healthcare solutions. This Swedish multinational healthcare company emphasizes patient-centric care and combines medical expertise with the latest technological advancements to ensure optimal health outcomes for its customers. With a strong focus on preventive care, Medicover AB aims to promote and facilitate healthier lifestyles.
Medicover AB is primarily active in the healthcare industry.
The main competitors of Medicover AB in the market include listed healthcare companies such as Capio AB, Ramsay Générale de Santé, and Fresenius SE & Co. KGaA. These competitors operate in various healthcare segments, including primary care, hospital care, and diagnostic services. However, Medicover AB differentiates itself through its integrated healthcare model, providing a comprehensive range of services covering primary and specialty care, diagnostic imaging, and laboratory analysis. With a strong focus on patient-centric care and technological innovation, Medicover AB remains a key player in the competitive healthcare market.
Medicover AB is a renowned healthcare company specializing in medical services, diagnostics, and fertility treatments. Founded in 1995, Medicover has grown to become a leading provider of private healthcare services across Europe. With a strong presence in 15 countries, Medicover offers a wide range of services, including primary care, specialty care, hospital services, and laboratory diagnostics. The company's commitment to exceptional patient care, advanced medical technologies, and innovative solutions has earned them a trusted reputation in the healthcare industry. Medicover AB continues to expand its operations globally, providing quality healthcare solutions to individuals and families worldwide.
Medicover AB, a leading healthcare and diagnostic services provider, has achieved several significant milestones. The company's commitment to providing high-quality healthcare has led to expanding its presence in various countries, resulting in a strong global footprint. Medicover's milestones include successful acquisitions and collaborations with industry leaders to enhance its service offerings and geographic reach. Additionally, the company's focus on innovation and cutting-edge technology has led to the implementation of advanced medical solutions, improving patient outcomes. Medicover AB's remarkable achievements and continuous growth highlight its dedication to providing comprehensive and accessible healthcare solutions to individuals and communities worldwide.
Medicover AB is primarily present in various countries and regions across Europe. With its headquarters in Sweden, Medicover AB has a strong presence in Poland, Romania, Ukraine, Germany, Hungary, and Serbia. Through its extensive network of medical clinics, hospitals, and laboratories, Medicover AB provides a wide range of healthcare services, including primary care, specialist care, diagnostics, and laboratory work. The company's commitment to delivering high-quality healthcare services has earned it a reputation as a trusted healthcare provider in the regions where it operates.
Medicover AB represents a strong commitment to healthcare and quality services. With a focus on patient-centered care, the company promotes accessibility, innovation, and personalized medical solutions. Medicover AB strives to deliver comprehensive healthcare solutions by blending modern technology with a compassionate approach. Their corporate philosophy revolves around continuously improving patient outcomes and enhancing the overall healthcare experience. By combining the expertise of their dedicated professionals and advanced medical facilities, Medicover AB aims to provide exceptional healthcare services to individuals and families. This commitment to excellence and patient well-being is at the core of Medicover AB's values and corporate philosophy.
Analysts currently set an average price target of 23.83 EUR for the Medicover stock (median: 22.81 EUR), implying +3.2 % versus the latest price. The consensus is based on 9 analyst ratings.
9 analysts currently rate the Medicover stock: 5 recommend buying, 4 holding and 0 selling. For 2026, analysts expect Medicover to generate revenue of 2.59 B EUR and earnings per share of 0.06 EUR.
The Medicover share (MCOV B.ST) is listed on 8 stock exchanges, including: London (0RPS.L), Frankfurt (5M0B.F), München (5M0B.MU), Düsseldorf (5M0B.DU), Stockholm (MCOV B.ST).
Medicover AB is a multinational company operating in the healthcare, diagnostic, and nursing sectors. Its business model focuses on providing comprehensive healthcare to patients, from diagnostics to treatment. Medicover offers a wide range of services including general medicine, dentistry, gynecology, dermatology, ophthalmology, pediatrics, and more. The company also operates its own pharmacies and laboratories, and offers home care, elderly care, and psychiatric care. Medicover has a strong presence in Europe, with clinics and healthcare centers in various countries including Sweden, Poland, Germany, Romania, Hungary, Ukraine, and Slovakia. The company's strategy emphasizes innovation and effectiveness in meeting patients' healthcare needs, through collaboration with doctors and continuous professional development. Technology plays a crucial role in Medicover's business model, with the use of advanced medical devices, IT systems, and telemedicine to improve patient diagnosis and treatment. The company aims to provide comprehensive healthcare by integrating different healthcare services, and offers additional health products such as supplements, vitamins, and painkillers in its pharmacies. Overall, Medicover strives to improve patient healthcare through qualified staff, technology, and collaboration with industry professionals.
The expected revenue of Medicover is 2.59 B EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Medicover is 9.18 M EUR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Medicover is currently 379.74. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Medicover stock.
The price-to-sales ratio (P/S) of Medicover is currently 1.35. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Medicover stock.
The Eulerpool Quality Score for Medicover is 6/10.
The ISIN of Medicover is SE0009778848. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Medicover is A2DRQV. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Medicover is MCOV B.ST. The ticker symbol is used to trade Medicover shares on the stock exchange.
Medicover stock
Medicover Peer Group
Medicover Ticker
Medicover FIGI
All fundamentals and in-depth analysis of Medicover
Our stock analysis for Medicover stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medicover. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.